BTG Share PerformanceMore
|52 week high||739.5 12/07/16|
|52 week low||528.4 31/01/17|
|52 week change||35.5 (5.85%)|
|4 week volume||23,525,398 28/03/17|
Latest News« previous» nextMore
13/04/2017 - 16:43 RNS
RNS Number: 5060C BTG PLC 13 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii BTG Plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disposal of qua...
06/04/2017 - 08:28 StockMarketWire
BTG, the specialist healthcare company, said it expected revenue for the year ended 31 March to be at or above the upper en...
06/04/2017 - 07:00 RNS
RNS Number: 7162B BTG PLC 06 April 2017 BTG plc: close period update London, UK, 6 April, 2017: BTG plc (LSE:BTG), the specialist healthcare company, provides the following update for the year ended 31 March 2017 ahead of the publication of its Final Results on 16 May 2017. Louise Makin, CEO of BTG, commented: " Our business has performed well this year. W...
03/04/2017 - 10:24 RNS
RNS Number: 3602B BTG PLC 03 April 2017 3 April 2017 BLOCK LISTING RETURN For period 4 October 2016 to 3 April 2017 Name of applicant: BTG plc Name of scheme BTG Executive Share Option Scheme BTG Performance Share Plan BTG Sharesave Scheme BTG US Stock Purchase Plan Total Balance under scheme from previous return 1,090,169 119,724 65,0...
02/03/2017 - 15:03 RNS
RNS Number: 3813Y BTG PLC 02 March 2017 2 March 2017 BTG plc - To tal Voting Rights and Share Capital In accordance with FCA's Disclosure and Transparency Rule 5.6.1, BTG plc (the "Company") notifies that as at 2 March 2017: 1. the Company's issued share capital consists of 385,127,525 Ordinaryshares of 10p each admitted to trading, and each with one vote; 2....
27/02/2017 - 14:10 StockMarketWire
BTG has received 510(k) clearance from the US Food and Drug Administration in respect of its EKOS Control Unit 4.0, use...
27/02/2017 - 14:02 RNS
RNS Number: 9151X BTG PLC 27 February 2017 BTG Receives U.S. FDA 510(k) Clearance for EKOS Control Unit 4.0 London, UK, 27 February 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today announced U.S. Food and Drug Administration 510(k) clearance has been granted to the EKOS Control Unit 4.0. The EKOS system includes an ultraso...
01/02/2017 - 13:10 RNS
RNS Number: 7604V BTG PLC 01 February 2017 1 February 2017 BTG plc - To tal Voting Rights and Share Capital In accordance with FCA's Disclosure and Transparency Rule 5.6.1, BTG plc (the "Company") notifies that as at 1 February 2017: 1. the Company's issued share capital consists of 385,099,960 Ordinaryshares of 10p each admitted to trading, and each with one...
|Dividend yield||0 %|
Equity Research (BTG)
Growth across all three divisions of BTG’s Interventional Medicine (IM) franchise (oncology, vascular and pulmonology), coupled with currency tailwinds, helped push FY16 revenue towards the upper end...
BTG’s interim results have driven upgrades to our financial forecasts with a small boost to revenues from one-off Zytiga backdated royalties. Our operating expenses are broadly unchanged, but...
BTG’s close period update saw a revision to its FY16 revenue guidance, targeting sales in the lower half of £410-440m (at $1.61/£). This is based on slower-than-expected Varithena sales, despite a...
- 1 of 3
Latest discussion posts More
“pauloverdi This must be on some ones radar by now. Hopefully we can hold around the #6 mark with a bid coming in for at least #8.. Did you notice that the pound is ...”▼
“"The mm's giveth and the mm's taketh away" the most frustrating share on the LSE !!”▼
“With this and the other major institutional holdings accounting for over 35% Inmo t BTG will taken over during the coming year. Growth looks set to return with no more finds ...”▼
Codes & Symbols
|Symbols||BTG, LSE:BTG, BTG.L, BTG:LN, LON:BTG, XLON:BTG|